Selank: Mechanistic Overview
internal_protocol · clinical · status: needs_provider_review
Metadata
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
Embedding: pending
File: signed link
Summary (generated — provider review required)
Selank is a synthetic analog of the immunomodulatory peptide tuftsin, approved in Russia for anxiety; Western evidence is limited. Mechanism: anxiolytic and immunomodulatory effects, with reported influence on GABA/serotonergic systems and BDNF. Relevance: anxiety, dysautonomia-adjacent, and neuroinflammatory presentations.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (4) · phenotypes (1)
evidence_reference, mechanism, safety_reference, dosing_reference
Phenotypes: dysautonomia
Evidence claims (4) · review items (3)
regulatory · pending
Selank is a synthetic analog of the immunomodulatory peptide tuftsin, approved in Russia for anxiety; Western evidence is limited.
mechanism · pending
Mechanism: anxiolytic and immunomodulatory effects, with reported influence on GABA/serotonergic systems and BDNF.
safety · pending
Safety: intranasal; investigational outside Russia.
dosing · pending
Mechanistic background for provider review only — not a treatment recommendation or dosing guidance.
Extracted chunks (1)
57 approx tokens across 1 chunks.